These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 225007)

  • 1. Cell kinetic analyses of human malignant brain tumors (gliomas).
    Hoshino T; Wilson CB
    Cancer; 1979 Sep; 44(3):956-62. PubMed ID: 225007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme.
    Hoshino T; Townsend JJ; Muraoka I; Wilson CB
    Brain; 1980 Dec; 103(4):967-84. PubMed ID: 6254610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas.
    Hoshino T
    J Neurosurg; 1984 Nov; 61(5):895-900. PubMed ID: 6491735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in the proliferative potential of human gliomas.
    Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
    J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
    Hoshino T; Ahn D; Prados MD; Lamborn K; Wilson CB
    Int J Cancer; 1993 Feb; 53(4):550-5. PubMed ID: 8382191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell kinetic investigations in brain tumors studied by serial stereotactic biopsy.
    Franzini A; Ferraresi S; Giorgi C; Costa A; Allegranza A; Broggi G
    J Neurooncol; 1989 Nov; 7(4):373-9. PubMed ID: 2685184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stathmokinetic (mitostatic) effect of vincristine and vinblastine on human gliomas.
    Hoshino T; Wilson CB; Muraoka I
    Acta Neuropathol; 1979 Jun; 47(1):21-5. PubMed ID: 463503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
    Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL
    J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
    Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
    Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of malignant gliomas.
    Bruner JM
    Semin Oncol; 1994 Apr; 21(2):126-38. PubMed ID: 8153659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
    Zuber P; Hamou MF; de Tribolet N
    Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
    Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
    Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative potential of malignant glioma cells before and after interstitial brachytherapy.
    Kunishio K; Matsumoto K; Higashi H; Adachi H; Tamiya T; Furuta T; Ohmoto T
    Neurol Med Chir (Tokyo); 1999 May; 39(5):341-9. PubMed ID: 10481436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
    Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
    J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions in vascular and neoplastic cells of human gliomas.
    Hara A; Sakai N; Yamada H; Hirayama H; Tanaka T; Mori H
    Neurosurgery; 1991 Aug; 29(2):211-5. PubMed ID: 1715979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative potential and outcome in pediatric astrocytic tumors.
    Prados MD; Krouwer HG; Edwards MS; Cogen PH; Davis RL; Hoshino T
    J Neurooncol; 1992 Jul; 13(3):277-82. PubMed ID: 1325544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.